HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis: Results from five hemodialysis units in central Greece

Journal of Clinical Virology

Volumn 34, Issue 1, 2005, Pages 81-85

  Rigopoulou, Eirini I ^a   Stefanidis, Ioannis ^a   Liaskos, Christos ^a   Zervou, Eleftheria K ^b   Rizos, Christos ^a   Mina, Paraskevi ^a   Zachou, Kalliopi ^a   Syrganis, Christos ^c   Patsidis, Eftichios ^d   Kyriakopoulos, George ^e   Sdrakas, Lambros ^f   Tsianas, Nikolaos ^g   Dalekos, Georgios N ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c General Hospital of Volos   (Greece)

^d Renal Unit   (Greece)

^e GENERAL HOSPITAL OF LARISSA   (Greece)

^f General Hospital of Karditsa   (Greece)

^g General Hospital of Trikala   (Greece)

Author keywords

HCV RNA; Hemodialysis; Hepatitis C virus; TMA

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; ASSAY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE AMPLIFICATION; GENOTYPE; GREECE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RNA ANALYSIS; RNA TRANSCRIPTION; SENSITIVITY ANALYSIS; VIREMIA;

FEMALE; GENE AMPLIFICATION; GREECE; HEPACIVIRUS; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION, GENETIC;

EID: 23744515637     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2005.05.007     Document Type: Article

References (27)

1. J. Bukh, P. Wantzin, K. Krogsgaard, F. Knudsen, R.H. Purcell, and R.H. Miller High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group J Infect Dis 168 1993 1343 1348
2. L. Comanor, F. Anderson, M. Ghany, R. Perrillo, E.J. Heathcote, and C. Sherlock Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV-RNA at end of treatment Am J Gastroenterol 96 2001 2968 2972
3. L. Comanor, C. Elkin, K. Leung, M. Krajden, K. Kronquist, and K. Nicolas Successful HCV genotyping of previously failed and low viral load specimens using an HCV-RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay J Clin Virol 28 2003 14 26
4. G.N. Dalekos, E. Zervou, F. Karabini, M. Elisaf, K. Bourantas, and K.C. Siamopoulos Prevalence of antibodies to human T-lymphotropic virus types I and II in volunteer blood donors and high-risk groups in northwestern Greece Transfusion 35 1995 503 506
5. G.N. Dalekos, D.S. Boumba, K. Katopodis, E. Zervou, G. Sferopoulos, and M. Elisaf Absence of HCV viraemia in anti-HCV-negative haemodialysis patients Nephrol Dial Transplant 13 1998 1804 1806
6. G.N. Dalekos, E. Zervou, M. Elisaf, N. Germanos, E. Galanakis, and K. Bourantas Antibodies to hepatitis E virus among several populations in Greece: increased prevalence in an hemodialysis unit Transfusion 38 1998 589 595
7. I. Diamantis, I. Vafiadis, E. Voskaridou, J. Dellatetsima, N. Jaggi, and K. Gyr Genotype distribution of hepatitis C virus infection in Greece: correlation with different risk factors and response to interferon therapy Eur J Gastroenterol Hepatol 10 1998 75 79
8. F. Fabrizi, F.F. Poordad, and P. Martin Hepatitis C infection and the patient with end-stage renal disease Hepatology 36 2002 3 10
9. F. Fabrizi, S. Bunnapradist, G. Lunghi, and P. Martin Kinetics of hepatitis C virus load during hemodialysis: novel perspectives J Nephrol 16 2003 467 475
10. N. Furusyo, J. Hayashi, I. Ariyama, Y. Sawayama, Y. Etoh, and M. Shigematsu Maintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infection Am J Gastroenterol 95 2000 490 496
11. M. Girndt, M. Sester, U. Sester, H. Kaul, and H. Kohler Molecular aspects of T- and B-cell function in uremia Kidney Int Suppl 78 2001 206 211
12. D.A. Hendricks, M. Friesenhahn, L. Tanimoto, B. Goergen, D. Dodge, and L. Comanor Multicenter evaluation of the VERSANT HCV-RNA qualitative assay for detection of hepatitis C virus RNA J Clin Microbiol 41 2003 651 656
13. H. Hinrichsen, G. Leimenstoll, G. Stegen, H. Schrader, U.R. Folsch, and W.E. Schmidt Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients Gut 51 2002 429 433
14. N. Khan, S. Aswad, H. Shidban, M. Aghajani, R. Mendez, and L. Comanor Improved detection of HCV Infection in hemodialysis patients using a new HCV-RNA qualitative assay: experience of a transplant center J Clin Virol 30 2004 175 182
15. S.N. Natov, and B.J. Pereira Hepatitis C in dialysis patients Adv Ren Replace Ther 3 1996 275 283
16. S. Saab, P. Martin, M. Brezina, G. Gitnick, and H.F. Yee Jr. Serum alanine aminotransferase in hepatitis c screening of patients on hemodialysis Am J Kidney Dis 37 2001 308 315
17. S. Saab, M. Brezina, G. Gitnick, P. Martin, and H.F. Yee Jr. Hepatitis C screening strategies in hemodialysis patients Am J Kidney Dis 38 2001 91 97
18. N. Sakamoto, N. Enomoto, F. Marumo, and C. Sato Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma J Med Virol 39 1993 11 15
19. C. Sarrazin, D.A. Hendricks, F. Sedarati, and S. Zeuzem Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a J Clin Microbiol 39 2001 2850 2855
20. P.M. Schneeberger, I. Keur, W. van der Vliet, K. van Hoek, H. Boswijk, and A.M. van Loon Hepatitis C virus infections in dialysis centers in The Netherlands: a national survey by serological and molecular methods J Clin Microbiol 36 1998 1711 1715
21. U. Sester, M. Sester, M. Hauk, H. Kaul, H. Kohler, and M. Girndt T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients Nephrol Dial Transplant 15 2000 1217 1223
22. D. Siagris, C. Labropoulou-Karatza, M. Christofidou, D. Goumenos, K. Thomopoulos, and A. Lekkou Viraemia, cryoglobulins and autoantibodies in haemodialysis patients infected with hepatitis C virus Eur J Gastroenterol Hepatol 15 2003 133 137
23. E. Silini, F. Bono, A. Cerino, V. Piazza, E. Solcia, and M.U. Mondelli Virological features of hepatitis C virus infection in hemodialysis patients J Clin Microbiol 31 1993 2913 2917
24. I. Stefanidis, E.K. Zervou, C. Rizos, C. Syrganis, E. Patsidis, and G. Kyriakopoulos Hepatitis E virus antibodies in hemodialysis patients: an epidemiological survey in central Greece Int J Artif Organs 27 2004 842 847
25. K. Yasuda, K. Okuda, N. Endo, Y. Ishiwatari, R. Ikeda, and H. Hayashi Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal Gastroenterology 109 1995 1295 1300
26. E.K. Zervou, D.S. Boumba, C. Liaskos, S. Georgiadou, E.V. Tsianos, and G.N. Dalekos Low prevalence of HCV, HIV, and HTLV-I/II infection markers in northwestern Greece: results of a 3-year prospective donor study(1995-1997) Eur J Intern Med 14 2003 39 44
27. E.K. Zervou, S. Georgiadou, M. Tzilianos, P. Georgitsi, V. Pournara, and S. Nousis Human T-lymphotropic virus type I/II infections in volunteer blood donors from Northern and Western Greece: increased prevalence in one blood bank unit Eur J Intern Med 15 2004 422 427